DK-60251/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Pyridoxamine: the many virtues of a maillard reaction inhibitor.

Voziyan PA, Hudson BG. Voziyan PA, et al. Ann N Y Acad Sci. 2005 Jun;1043:807-16. doi: 10.1196/annals.1333.093. Ann N Y Acad Sci. 2005. PMID: 16037308 Review.

Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.

Voziyan PA, Hudson BG. Voziyan PA, et al. Cell Mol Life Sci. 2005 Aug;62(15):1671-81. doi: 10.1007/s00018-005-5082-7. Cell Mol Life Sci. 2005. PMID: 15905958 Free PMC article. Review.

Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG. Scheinman JI, et al. Urol Res. 2005 Nov;33(5):368-71. doi: 10.1007/s00240-005-0493-3. Epub 2005 Nov 15. Urol Res. 2005. PMID: 16292584

Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Chetyrkin SV, et al. Kidney Int. 2005 Jan;67(1):53-60. doi: 10.1111/j.1523-1755.2005.00054.x. Kidney Int. 2005. PMID: 15610227 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters